Mineralys Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $25.52 |
Previous Close | $26.01 |
Day Range | $25.25-$25.52 |
52W Range | $22-$47.65 |
Market Cap | $2.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.20 |
News
See moreYahoo Finance • last month
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
Yahoo Finance • last month
What to Know About This Mineralys Insider Sale Before a December FDA Date
Yahoo Finance • 2 months ago
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Yahoo Finance • 3 months ago
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
About
CEO | Dr. Jon Congleton |
CFO | Mr. Adam Scott Levy |
Address | 150 N. Radnor Chester Road, Radnor, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |